Literature DB >> 28242998

18F-FDG PET/CT/MRI Fusion Images Showing Cranial and Peripheral Nerve Involvement in Neurolymphomatosis.

Ana Carolina Trevisan1, Fernanda Borges Ribeiro2, Emerson Nobuyuki Itikawa1, Leonardo Santos Alexandre3, Felipe Arriva Pitella3, Antonio Carlos Santos3, Belinda Pinto Simões2, Lauro Wichert-Ana1.   

Abstract

We report a 56-year-old female patient with non-Hodgkin's diffuse large B cell lymphoma (NHL) who, on magnetic resonance imaging (MRI) with a T1 weighted and gadolinium-enhanced imaging, was found to have thickening and infiltration in 75% of peripheral nerves of the patient and enlargements of cranial nerves, possibly related to lymphomatous infiltration. Subsequent positron emission tomography/computed tomography (PET/CT) using 18F-labeled 2-deoxy-2-fluoro-d-glucose (18F-FDG) showed widespread active involvement of the cervical plexus, bilateral peripheral nerves, right femoral nerve, the parasellar region of the skull, and marked hypermetabolism in the left trigeminal ganglia. This case re-emphasizes that while CT and MRI provide anatomical details, 18F-FDG PET/CT images better delineate the metabolic activity of neurolymphomatosis (NL) in the peripheral and central nervous system.

Entities:  

Keywords:  18F-FDG; PET/CT; neurolymphomatosis; non-Hodgkin lymphoma

Year:  2017        PMID: 28242998      PMCID: PMC5317084          DOI: 10.4103/0972-3919.198502

Source DB:  PubMed          Journal:  Indian J Nucl Med        ISSN: 0974-0244


A 56-Year-Old Female Patient With Non-Hodgkin's Diffuse Large B-Cell Lymphoma (Nhl) Presenting With Hoarseness, Nasal Obstruction, Left Facial Paralysis, and Numbness Was Confirmed to Have Aseptic Meningitis on Lumbar Puncture Examination. Treatment Started for Meningitis and Chemotherapy for Lymphoma. the Patient Continued to Show Clinical and Neurological Deterioration With Confused State and a Decreased Level of Consciousness. Gadolinium-Enhanced T1 Weighted Magnetic Resonance Imaging (Mri) Image Showed Thickening and Infiltration in 75% of Peripheral Nerves of the Patient and Enlargements of Cranial Nerves, Possibly Related to Lymphomatous Infiltration. Subsequently Patient Was Subjected to18 f-Labeled 2-Deoxy-2-Fluoro-d-Glucose (18 f-Fdg) Positron Emission Tomography/computed Tomography (Pet/ct) [Figure 1].
Figure 1

18F-FDG PET/CT/MRI fusion showed thickening and infiltration in 75% of peripheral nerves and enlargements of cranial nerves in the parasellar region of the skull with marked hypermetabolism in the left trigeminal ganglia (A), possibly related to lymphomatous infiltration. 18F-FDG PET/CT showing widespread active involvement of the cervical plexus, bilateral peripheral nerves, and Right femoral nerve (B) with a conspicuous lymphomatous infiltration through the lateral foramina in the lumbar spine (C). (R, Right; L, left; A, anterior; P, posterior)

18F-FDG PET/CT/MRI fusion showed thickening and infiltration in 75% of peripheral nerves and enlargements of cranial nerves in the parasellar region of the skull with marked hypermetabolism in the left trigeminal ganglia (A), possibly related to lymphomatous infiltration. 18F-FDG PET/CT showing widespread active involvement of the cervical plexus, bilateral peripheral nerves, and Right femoral nerve (B) with a conspicuous lymphomatous infiltration through the lateral foramina in the lumbar spine (C). (R, Right; L, left; A, anterior; P, posterior) Neurolymphomatosis (NL) is a rare disorder characterized by infiltration of nerves, aggressive subtypes of NHL or leukemia.[12] It is related to peripheral nervous system infiltration by lymphomatous lymphocytes cells of cranial nerves, trunk nerves, nerve roots, and plexus in the setting of a hematologic malignancy.[3] Most commonly, NL presents as a painful polyneuropathy or polyradiculopathy, followed by cranial neuropathy, painless polyneuropathy, and peripheral mononeuropathy.[4] Diagnosis requires a high index of clinical suspicion and histopathologic confirmation of an involved nerve by biopsy, or at autopsy. Brain and spinal nerves MRI, and CT of the trunk are essential in providing an overview of the structural involvement, but in some cases, just anatomic images can be ineffective in showing the active malignancy.[5] In this setting, PET/CT is being highly recommended to evaluate the extent of disease throughout the body complementing the anatomical images.[678] This case evidences that 18F-FDG PET/CT images better delineated the metabolic activity of NL in the peripheral and central nervous system.

Financial support and sponsorship

Nil.

Conflicts of interest

There are no conflicts of interest.
  8 in total

1.  Neurolymphomatosis: an International Primary CNS Lymphoma Collaborative Group report.

Authors:  Sigal Grisariu; Batia Avni; Tracy T Batchelor; Martin J van den Bent; Felix Bokstein; David Schiff; Outi Kuittinen; Marc C Chamberlain; Patrick Roth; Anatoly Nemets; Edna Shalom; Dina Ben-Yehuda; Tali Siegal
Journal:  Blood       Date:  2010-04-05       Impact factor: 22.113

2.  Neurolymphomatosis: diagnosis, management, and outcomes in patients treated with rituximab.

Authors:  Hui K Gan; Arun Azad; Lawrence Cher; Paul L R Mitchell
Journal:  Neuro Oncol       Date:  2009-12-24       Impact factor: 12.300

Review 3.  Diagnosis and management of neurolymphomatosis.

Authors:  Joachim M Baehring; Tracy T Batchelor
Journal:  Cancer J       Date:  2012 Sep-Oct       Impact factor: 3.360

4.  Neurolymphomatosis.

Authors:  Joachim M Baehring; Denise Damek; Emily C Martin; Rebecca A Betensky; Fred H Hochberg
Journal:  Neuro Oncol       Date:  2003-04       Impact factor: 12.300

5.  Usefulness of 18F-FDG PET/CT in the detection of neurolymphomatosis.

Authors:  Wen-lan Zhou; Hu-bing Wu; Can-shuo Weng; Yan-jiang Han; Meng Wang; Shun Huang; Quan-shi Wang
Journal:  Nucl Med Commun       Date:  2014-11       Impact factor: 1.690

6.  Positron emission tomography/computerized tomography imaging of multiple focus of neurolymphomatosis.

Authors:  James Peterson; Billur Caliskan; Shahram Bonyadlou
Journal:  Indian J Nucl Med       Date:  2014-10

Review 7.  Neurolymphomatosis in a patient with extranodal NK/T-cell lymphoma, nasal-type: a case report and literature review.

Authors:  Ikuo Shimizu; Yujiro Hamano; Shunichi Sato; Wataru Takeda; Takehiko Kirihara; Keijiro Sato; Toshimitsu Ueki; Yuki Hiroshima; Masahiko Sumi; Mayumi Ueno; Naoaki Ichikawa; Hikaru Kobayashi
Journal:  Intern Med       Date:  2014       Impact factor: 1.271

8.  CNS involvement in the non-Hodgkin's lymphomas.

Authors:  L J Levitt; D M Dawson; D S Rosenthal; W C Moloney
Journal:  Cancer       Date:  1980-02       Impact factor: 6.860

  8 in total
  1 in total

1.  TRIM3 attenuates apoptosis in Parkinson's disease via activating PI3K/AKT signal pathway.

Authors:  Wenwen Dong; Bei Luo; Chang Qiu; Xu Jiang; Bo Shen; Li Zhang; Weiguo Liu; Wenbin Zhang
Journal:  Aging (Albany NY)       Date:  2020-11-30       Impact factor: 5.682

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.